Restoration

EP3538221

PEDIATRIC HUMAN DOSING OF THE ANTI-CD30 ANTIBODY-DRUG CONJUGATE BRENTUXIMAB VEDOTIN

  • :
    EP einkaleyfi: Þýðing ekki lögð inn
  • :
    13.11.2017
  • :
    9.10.2024
  • :
    17808270.7
  • :
    12.11.2037
  • :
    PEDIATRIC HUMAN DOSING OF THE ANTI-CD30 ANTIBODY-DRUG CONJUGATE BRENTUXIMAB VEDOTIN

13.11.2017
9.10.2024
  • :
    Takeda Pharmaceutical Company Limited
  • :
    1-1, Doshomachi 4-chome, Chuo-ku,, Osaka-shi, Osaka, JP
  • :
    FASANMADE, Adedigbo
  • :
    Cambridge MA 02139, US
  • :
    201662421527 P
  • :
    14.11.2016
  • :
    US
  • :
    US2017061294
  • :
    13.11.2017
  • :
    A61K 39/395, A61P 35/00, A61K 31/475, A61K 31/573, A61K 31/655, A61K 31/675, A61K 31/704, A61K 45/06, A61K 47/68